Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthem, Inc.
Pharmaceutical company raises 2003 outlook
May 14th, 2003
Anthem, Inc., (ATH) announced that it expects to report earnings of $1.36 per diluted share for the first quarter of 2003, a 43% increase compared to the first quarter of 2002. The company's adjusted earnings are expected to reach $1.18 per share, excluding $0.11 per share for a previously disclosed benefit following resolution of a litigation matter and $0.07 per share for realized gains on investments. These results exceed the company's prior adjusted earnings expectations of $1.00 to $1.05 per share. "We are pleased with the momentum demonstrated in our financial performance through the first 3 months of 2003. Our results reflect lower than...
Source: Biotech Week (2003-05-14)
|
